                                                                     Human Molecular Genetics, 2009, Vol. 18,  4          595–606
                                                                     doi:10.1093/hmg/ddn384
                                                                     Advance Access published November 13, 2008


Zebrafish Tsc1 reveals functional interactions cilium TOR pathway
Linda M. DiBella, Alice Park Zhaoxia Sun

Department Genetics, Yale University School Medicine, New Haven, CT 06520, USA

Received August 5, 2008; Revised Accepted November 11, 2008

 cell surface organelle called cilium essential preventing kidney cyst formation establish-
ing left– right asymmetry vertebrate body plan. Recent advances suggest cilium functions sensory organelle vertebrate cells multiple signaling pathways hedgehog Wnt path-
ways. Prompted kidney cyst formation tuberous sclerosis complex (TSC) patients rodent models, investigated role cilium TSC– target rapamycin (TOR) pathway using zebrafish. TSC1 TSC2 genes causal TSC, protein products form complex TOR pathway inte-
grates environmental signals regulate cell growth, proliferation survival. TSC1 homologs identified zebrafish, refer tsc1a tsc1b. Morpholino knockdown tsc1a led ciliary
phenotype including kidney cyst formation left –right asymmetry defects. Tsc1a observed localize Golgi, morpholinos  nonetheless, acted synthetically ciliary genes producing
kidney cysts. Consistent role cilium pathway Tsc genes, TOR pathway aber-
rantly activated ciliary mutants, resembling effect tsc1a knockdown.  kidney cyst 
mation ciliary mutants blocked Tor inhibitor, rapamycin. Surprisingly, observed
elongation cilia tsc1a knockdown animals.  data suggest signaling network cilium TOR pathway ciliary signals feed TOR pathway Tsc1a regulates length cilium itself.




INTRODUCTION                                                          linked autosomal-dominant polycystic kidney disease
                                                                      (ADPKD) mice (14,15). studies demonstrated Protruding cell surface environment,            defects cilia formation function renal epithelial
cilium ideally situated function antenna          cells lead cyst formation. Consistent important sig-
cell. vertebrate cells, cilium ubiquitously          naling role cilium vertebrate systems, defects present multiple signaling receptors, including PDGFRa            ciliary formation function lead early develop- G protein-coupled receptors, localized           mental deficiencies, notably abnormal left – right asym-
cilium (1 – 3), suggesting unique role cilium mediat-     metry body plan (16 – 18). addition, defects IFT
ing extra-cellular signals downstream pathways. agree-          mice implicated aberrant Hedgehog sig-
ment sensory role, recently, cilium               naling, resulting abnormalities neural tube patterning
linked growing list signaling pathways            limb development (7,8).
hedgehog Wnt pathways (4 – 11).                                  Kidney cysts, epithelium-lined liquid-filled
   Intraflagellar transport (IFT) process involved ciliary    sacs, thought result proliferation assembly maintenance, delivers recycles ciliary         renal epithelial cells hallmarks PKD (19). Impor-
components cilium, respectively (12). IFT         tantly, cilium center PKD. Multiple originally observed flagella green algae,           PKD genes, PKD1, PKD2, INVERSIN Bardet –
Chlamydomonas (13), significance regard               Biedl syndrome genes, linked cilium directly
ciliary formation function realized Chlamydo-          indirectly (reviewed 20). Conversely, mutations disrupt-
monas homolog IFT particle polypeptide ift88/polaris           ing cilia formation function kidney 

 correspondence addressed  NSB 393, PO Box 208005, 333 Cedar Street, New Haven, CT 06520, USA. Tel: þ1 2037853589;
Fax: þ1 2037857227; Email: zhaoxia.sun@yale.edu

# Author 2008. Published Oxford University Press. rights reserved. Permissions, email: journals.permissions@oxfordjournals.org
 596     Human Molecular Genetics, 2009, Vol. 18,  4


inevitably lead kidney cyst formation. results led      data suggest existence interactive cilium model PKD, postulates cilia            network cilium TOR pathway, ciliary
renal epithelial cells transduce anti-proliferative signal      signals regulate TOR pathway Tsc1a cells (12,21). Ciliary defects lead cell     involved cilia length control. proliferation eventually kidney cyst formation.  downstream molecular pathways responsible cilium-mediated cell proliferation fully     RESULTS
understood.                                                        TSC1 homologs zebrafish genome
   Intriguingly, addition PKD, kidney cyst formation frequently seen disease, tuberous sclerosis        analyze tsc1 function zebrafish, BLAST searched complex (TSC), autosomal-dominant genetic disorder              zebrafish-annotated genome database (VEGA) NCBI
characterized benign tumors develop numerous            EST non-redundant databases Tsc1 homologs. organs (reviewed 22). Mutations single allele    identified Tsc1-like genes, located chromosomes 5 TSC1 TSC2 gene lead TSC.  believed         21, refer tsc1a tsc1b. development disease requires somatic inacti-       genes encode predicted proteins 126 137 kDa vation second wild-type TSC allele (23). role        44  identical  share 36 44 
TSC genes kidney cyst formation supported        sequence identity, respectively, human hamartin
Eker rat model, carries germline mutation           (TSC1) protein. BLAST searches mammalian databases
allele Tsc2 develops early onset PKD (24,25).       protein yielded TSC1 hit, supporting  humans, large deletions removing TSC2            idea orthologs TSC1. gene adjacent PKD1 gene PKD             orthologs fish, refer fish proteins Tsc1a
patients severe early onset symptoms (26).           Tsc1b, instead hamartin. finding raises possi-
   Tsc1  known Hamartin) Tsc2  known          bility cellular functions associated mammalian Tuberin) proteins play defined role target     Tsc1 partitioned Tsc1 homologs zebrafish.
rapamycin (TOR) pathway: form heterodimer             assess conservation TOR pathway zebrafish,
negatively regulate TOR kinase eventually regulate         performed blast searches components TOR
cell growth, proliferation survival (reviewed 27).          pathway using Zv7 assembly zebrafish genome.    Given critical role cilium PKD, observation   addition previously known homologs S6K, rictor, kidney cyst formation TSC raises interesting question:    raptor TOR (33), single homologs Tsc2 Rheb cilium plays role TSC – TOR pathway.       identified (data shown).
date, role Tsc genes development remains fully analyzed. Tsc1 Tsc2 essential genes mouse knockouts die embryonic day 10.5 open             Knockdown tsc1a leads kidney cyst formation
neural tube phenotype (28,29). early lethality precludes      body curvature zebrafish analysis kidney cyst formation mouse knockout      study function tsc1a tsc1b zebrafish develop-
models, status laterality TSC mutants        ment, designed morpholino oligonucleotides unclear.  emerging evidence supports functional          translational initiation site Tsc1a Tsc1b (AUG
link cilium TSC/TOR pathway.               morpholino). 0.25 – 0.50 pmol oligo injected
example, studies mouse tissue culture suggest          1 – 4-cell stage embryos. Knockdown Tsc1a produced
PKD1, causal gene ADPKD, interacts TSC1 –           phenotypes similar seen multiple known cystic
mammalian TOR (mTOR) pathway (30,31). Intriguingly,                kidney mutants, including ift mutants (17) (Fig. 1A
rapamycin, inhibitor mTOR, delay cyst progression        B). specifically, tsc1a morphant embryos exhib- rodent PKD models (30).                                         ited ventral-directed body curvature (69 ) bilateral
   Based evidence, postulated cilium      cysts (51 , n ¼ 132) located tubular/glomerular regulate TSC – TOR pathway. tested hypoth-          region pronephros. tsc1b morphant embryos, esis examining tsc1 loss function phenotypes         contrast, developed curved bodies, lacked kidney cysts
status TOR pathway available ciliary mutants           Supplementary Material, Fig. S1). focused zebrafish model  Multiple ciliary mutants          analysis tsc1a morphants. verify specificity isolated previous genetic screens zebrafish             tsc1a morpholino, tested control morpholino
(17,32). Notably, reduction multiple IFT genes,           mismatched bases. control oligo encode components IFT particles (12,13), leads kidney        potent producing body curvature kidney cyst
cyst formation, laterality defects ventrally curved body       phenotype (2  cysts 9  body curvature). axes (17,18).    knockdown tsc1a         test specificity observed phenotypes, injected zebrafish leads phenotypes characteristic ciliary            morpholino blocking splice site tsc1a mutants; (ii) tsc1a genetically interacts IFT genes; (iii)    generated similar cystic kidney body curvature pheno- TOR pathway regulated ift morphants (knockdown        type (data shown). RT – PCR confirmed Tsc1a
animals generated injection anti-sense morpholino            transcript disrupted, tsc1b transcript levels oligo), similar observed tsc1a morphants,       unaffected (Fig. 1C), verifying phenotype observed
Tor inhibitor rapamycin inhibit cyst formation ift          specific consequence tsc1a knockdown. ana-
mutants (iv) cilia abnormally long tsc1a morphants.     lyzed cystic kidney phenotype tsc1a morphant                                                                                        Human Molecular Genetics, 2009, Vol. 18,  4                      597




Figure 1. Phenotype Tsc1a knockdown zebrafish embryos.   cell stage wild-type embryos injected AUG morpolinos Tsc1a develop ventral-directed body curvature  embryo) compared uninjected controls  embryo). (B) close morphant   showing cyst
pointed arrow. (C) RT –PCR lysates wild-type tsc1a morphants injected splicing site morpholino, showing splicing blocked tsc1a transcript tsc1b mRNA unaffected. Primers actin used loading control. (D– J). Sections tsc1a morphants wild-type control embryos. Histological cross-sections day 3 wild-type (D) tsc1a morphant (E) embryos reveal cysts tubular glomerular
regions (black arrow) tsc1a knock fish. posterior regions, expansion pronephric duct lumens (arrow head) evident tsc1a embryos (G)
compared uninjected controls (F). (H) Drawing zebrafish embryo dorsal view. Dotted lines represent regions [glomeruli/tubules (D) (E) ducts (F) (G)] histological cross-sections taken. Transmission electron micrographs mid-duct regions wild-type   tsc1a (J)
embryos illustrate knock Tsc1a results duct lumen dilation decrease density microvilli pronephric cilia. WT,
wild-type; Mag, magnification 1000.
  histological cross-sections glomerular-                   mutant embryos, previously appreciated
tubular region, large cysts apparent tsc1a morphant                   link IFT cilium Tsc1’s regulatory role
embryo (Fig. 1D, E H). posterior regions, dilation                   growth proliferation, suggest func- pronephric duct lumens evident, compared wild-                    tional connection cilium Tsc1.
type embryos (Fig. 1F– H). addition, electron micrographs cross-sections taken mid-pronephric duct luminal expansion tsc1a morphants (Fig. 1I J).                       Tsc1a required establishment left – right defect accompanied appeared                             asymmetry body plan
decrease density microvilli. verify                         hallmark ciliary defects abnormal left –right
counted number intact microvilli EM cross-sections                     asymmetric body plan, observed wild-type tsc1a morphant kidney ducts                            human patients mouse zebrafish models average 45 47, respectively (n ¼ 5 ,                        (18,34 – 39). Accordingly, investigated significant difference (P ¼ 0.73). results indi-                   reduced levels Tsc1a produce laterality defects. cate number microvilli does change signifi-                      test  performed situ hybridization cmlc2
cantly, despite increase volume duct lumen.                    (cardiac myosin light chain 2), expressed atrial phenotypic similarities tsc1a morphants ift                      ventricular cardiomyocytes developing heart (36).
 598       Human Molecular Genetics, 2009, Vol. 18,  4




Figure 2. Tsc1a required left–right body patterning.   Dorsal view 26 hpf embryos, showing cardiac myosin light chain 2 (cmlc2) expression shifted centrally 36  tsc1a embryos compared 100  left-sided expression WT fish (summarized Table 1). (B) southpaw primarily
expressed left lateral plate mesoderm wild-type embryos randomly distributed tsc1a knockdown embryos. Dorsal view showing WT tsc1a
embryos 20 somite stage. spaw, southpaw.

 wild-type control embryos 26 hours post fertilization                      Table 1. Expression pattern cmlc2 southpaw
(hpf), cmlc2 expression left embryo 100  time (Fig. 2A Table 1),                          Probe        Sample       n         Left      Right       Center       Absent
64  tsc1a morphant embryos showed left-sided
expression (Fig. 2A Table 1), remaining 36                          Cmlc2        Uninj.        37       100        0           0            0
                                                                                              tsc1a         36        64        0          36            0
shifted centrally, suggesting heart jogging dis-                   Spaw         Uninj.        90        87        2           2            9
rupted embryos. narrow                                       tsc1a        155        29       20          27           24 stage tsc1a affects laterality, examined expression domain southpaw situ hybridization. south-                   southpaw samples, ‘center’ refers bilateral signal.
paw encodes nodal-related protein zebrafish ear-
liest known marker asymmetry zebrafish. control
embryos, southpaw correctly expressed left                     2 days post fertilization (dpf), embryos scored embryos 87  time (Fig. 2B), right bilateral                 presence pronephric cysts. Embryos injected single,
2  time  absent 9 . contrast, tsc1a mor-                    low-dose morpholinos (0.25 pmol) exhibited mild cystic
phants, southpaw expression observed left 29                       kidney phenotype, e. 17  tsc1a embryos cysts time, right 20 , bilateral 27  absent 24  time                    [Fig. 3A C (n ¼ 3, 151, 58 67 embryos), (Fig. 2B, tsc1a Table 1), suggesting tsc1a functions                    B C (n ¼ 3, 49 embryos), tsc1a]. Simi-
upstream southpaw, process closely associated                          larly, frequency cysts ift samples 9  ciliary functions.                                                          [Fig. 3A C (n ¼ 3, 70 embryos sample)
                                                                                 B C (n ¼ 3, 57 embryos sample),
                                                                                 ift]. doses morpholinos combined
tsc1a genetically interacts IFT genes                                        e. tsc1a ift81 ift172), dramatic increase fre- phenotypic similarities tsc1a morphants                          quency cysts [58 57 , respectively, Fig. 3C (n ¼ 3,
known ciliary mutants zebrafish suggest genes                      72 embryos sample)] observed function common cellular process. Partial knock-                        groups, suggesting synergistic additive key component cellular pathway                              effect (Fig. 3A B, tsc1a/ift; Fig. 3C, . addition
generates sensitized genetic background,                         increased frequency pronephric cysts, injected
background, disruption components                           embryos exhibited pronounced body curvature pheno-
pathway lead synergistic effect. specifically                  type (Fig. 3A B, tsc1a/ift). rule possi-
tested suboptimal doses tsc1a morpholino                      bility synergistic effect caused increased IFT morpholino synergize  Low                           morpholino oligo used double-injected
doses morpholinos tsc1a, ift81 ift172 injected                     samples, injected tsc1a morpholino wild-type embryos concentrations result                    standard control morpholino. Results showed low frequency, low severity phenotypes. Embryos                        inclusion control morpholino did affect pheno- injected similar doses tsc1a morpholinos combi-                    type significantly. Specifically, 11.4  embryos
nation ift antisense oligonucleotides.                 showed kidney cysts injected 0.17 pmol tsc1a
                                                                                      Human Molecular Genetics, 2009, Vol. 18,  4         599


                                                                                 immunofluorescence experiments day 1 wild-type
                                                                                 embryos using Tsc1-2 antibody antibodies                                                                                  g-tubulin, labels centrosome, acetylated
                                                                                 tubulin, labels cilium. obvious
                                                                                 overlap g-tubulin Tsc1a pronephric duct
                                                                                 (Fig. 4D). addition, Tsc1a localization cilium                                                                                  detection (data shown).
                                                                                    subcellular distribution pattern Tsc1a resembles                                                                                  Golgi complex. tested loca-
                                                                                 lized Golgi. used embryos different time
                                                                                 points: blastula stage 48 hpf. labeled cis-Golgi
                                                                                 using antibody structural components,
                                                                                 gm130, embryos blastula stage,                                                                                  largely overlaps Tsc1a (Fig. 4E). pronephric duct
                                                                                 48 hpf, similar pattern (Fig. 4G). pattern
                                                                                 overlap common embryo (data                                                                                  shown), suggesting Golgi complex                                                                                  primary site Tsc1a function. verify Tsc1a
                                                                                 localizes Golgi, wild-type blastula stage embryos                                                                                  incubated brefeldin (BFA) 1  dimethyl sulfoxide
                                                                                 (DMSO) 1  DMSO 60 min. BFA blocks
                                                                                 vesicle transport ER Golgi eventually
                                                                                 leads Golgi dispersal (41). DMSO-treated embryos,
                                                                                 Tsc1a partially overlapped gm130 perinuclear
Figure 3. synergistic interaction exists tsc1a ift genes. Sub-     pattern similar seen untreated embryos (Fig. 4E).
phenotypic doses AUG morpholinos tsc1a ift81               60 min 15 mg/ml BFA treatment,  caused ift172 (B) injected 1-cell, wild-type embryos injected indivi-
dually. coinjected embryos display dramatic increase frequency
                                                                                 gm130 Tsc1a signals disperse cyto- kidney cysts compared injected single morpholino        plasm cells, overlapping pattern (Fig. 4F),
bar graph, C) ( P , 0.01,  P , 0.02). mph, morphants.                         providing support Tsc1a protein                                                                                  associated cis-Golgi. Treatment BFA,
                                                                                  did phenocopy tsc1a morphants morpholino  10.5  showed kidney cyst                          embryos treated shield stage 50 mg/ml BFA injected tsc1a morpholino combination                           died day 2, indicating lack intact Golgi control morpholino (n ¼ 3, 24 embryos,                        severe consequences absence Tsc1a 
P ¼ 0.72).  findings provide genetic evidence tsc1a function similar pathway ift genes.
                                                                                 TOR pathway regulated zebrafish
                                                                                 tsc1a morphants ift morphants
Tsc1a localized Golgi complex                                          Tsc1 plays critical role growth proliferation control close association cilium Tsc1a suggests                      suppressing TOR pathway. ift mutants Tsc1a function cilium. determine                            similar phenotypes tsc1a morphants, asked subcellular localization pattern Tsc1a zebrafish                       TOR pathway aberrantly activated ift
embryos, developed polyclonal antibodies Tsc1a.                       mutants. Multiple markers used interrogate regions Tsc1a corresponding amino acids 580 –                          status mTOR pathway. example, elevated mTOR
736 980– 1108 fused maltose-binding protein                          activity leads phosphorylation activation p70S6K,
(MBP) different constructs. Recombinant proteins                          subsequently phosphorylates S6 leads generated bacteria used generate polyclonal                       increase ribosome biogenesis (42 – 44), levels antisera (Tsc1-1 Tsc1-2). antisera subsequently                     IRS1 drop negative feedback loop induced elev-
purified affinity purification. immunoblots, anti-                   ated mTOR activity (45,46). compared protein levels
bodies recognize 127 kDa band wild-type samples.                           phosphorylation levels key TOR components wild- signal greatly diminished lysates prepared                       type, tsc1a ift172 morphant embryos. expected, tsc1a morphant embryos  western blot using Tsc1-1 anti-                    TOR pathway activated tsc1a morphants (Fig. 5A).
body shown Fig. 4A). Immuno-staining experiments                           Excitingly, ift morphants similar change. Western
using Tsc1-2 antibody revealed Tsc1a ubiquitously                    blots performed 28 hpf embryo lysates revealed  expressed embryo (Fig. 4B). staining                          tsc1a ift172 morpholino-injected samples, phosphoryl-
signal greatly reduced tsc1a morphants (Fig. 4C), verify-                  ation TOR effector p70S6K (Pp70S6K), ing specificity antibody.                                             increased, level total p70S6Kwas unchanged
   previously reported Tsc1 localizes                    (Fig. 5A). Providing support regulation centrosome cell culture (40). determine Tsc1a                      TOR pathway, levels IRS1 reduced associates centrosome cilium, performed                       samples compared uninjected controls
 600       Human Molecular Genetics, 2009, Vol. 18,  4




Figure 4. Localization Tsc1a.   Affinity-purified Tsc1-1 antibodies recognize 126 kDa band diminished tsc1a embryo lysates. b-tubulin used loading control. (B) Tsc1a immunolocalization 1 dpf, mount embryos ubiquitous. (C) Knockdown Tsc1a using AUG morpholino tsc1a reduces Tsc1-2 signal. (D) Segment pronephric duct wild-type, 1 dpf embryo. Immunofluorescence using Tsc1-2 (green) anti-g-tubulin (red). Tsc1-2 signal does overlap centrosomes/basal bodies pronephric duct epithelial cells. (E) Tsc1-2 (green) fluor-
escent signal overlaps cis-Golgi marker gm130 (red) blastula-stage embryos. (F) Tsc1a (green) gm130 (red) signals disperse following
BFA treatment. (D–F) Nuclei stained DAPI (blue). (G) segment pronephric duct 2 dpf embryos. Tsc1a (Tsc1-2, green) significantly
colocalizes cis-Golgi (gm130, red). Nuclei stained TOTO-3. WT, wild-type; tsc1a, tsc1a morphant.



(Fig. 5A). reduction IRS1 levels moderate,                    inhibit TOR activity. Rapamycin effectively inhibit quantified changes using AutoQuant software, used                     TOR TORC1 complex mammals.  b-tubulin bands controls. results indicated                      directly tested rapamycin ift mutants. conservation IRS1 levels dropped 34 44  compared wild-type                           rapamycin activity zebrafish previously demon- tsc1a ift172 morphants, respectively.                      strated (33). Consistently, performing short incubation
data demonstrate ciliary defects lead aberrant                       wild-type, high stage embryos, tail bud stage
activation TOR pathway.                                                   500 nM rapamycin, able dramatic
                                                                                 drop Pp70S6K virtually undetectable levels compared
                                                                                 DMSO-treated embryos (Fig. 5B). cyst rescue
Rapamycin treatment partially rescue phenotypes                          experiments, titrated concentrations incubation ift57 ift81 mutants                                                        periods rapamycin concentrations Ectopic activation TOR pathway ift mutants/                            300 nM toxic embryos 0 dpf, suggested
morphants suggests way reverse phenotypes                      strong inhibition p70S6K severely detrimental.
                                                                                       Human Molecular Genetics, 2009, Vol. 18,  4                   601




Figure 5.   TOR pathway similarly regulated tsc1a ift172 morphants. Western blots performed day 1 deyolked, embryo
lysates. Levels activated p70S6K (Pp70S6K) elevated IRS1 levels reduced tsc1a ift172 morpholino-injected embryos compared uninjected controls (WT). Total p70S6K b-tubulin used loading controls. (B) Rapamycin function conserved zebrafish. Western blots Pp70S6K p70S6K control, lysates wild-type embryos treated 500 nM rapamycin 1  DMSO 1  DMSO high tail
bud stages. Pp70S6K signal absent rapamycin-treated sample, suggesting rapamycin suppressed TOR activity. (C) Rapamycin restricts pronephric cyst size ift mutant embryos. ift81 ift57 embryos incubated 200 300 nM rapamycin, respectively, 1  DMSO control, beginning 30 hpf. DMSO-treated embryos developed large pronephric cysts day 5;  cysts visible greatly
reduced size rapamycin-treated embryos.

 long-term incubation,  treated ift57 hi3417                  Table 2. Cyst area embryo length measurements derived ift57 ift81 hi409 mutants daily 300 200 nM rapamycin                     ift81 fish using Metamorph
1  DMSO control) beginning 30 hpf. day 5 development, took images treated embryos                             Strain       Treatment       n       Cyst area      Length      Area/length
(Fig. 5C) measured area cysts length fish
embryos using Metamorph. standardized cyst size                         Ift57        1  DMSO         14      10047          1738        5.78
                                                                                           300 nM rapa     15       1161          1756        0.66
dividing cyst area fish length. Results size                 Ift81        1  DMSO         11       3971          1541        2.58 cysts significantly reduced embryos treated                                 200 nM rapa     19        378          1537        0.25
rapamycin. average standardized cyst size DMSO-
treated ift57 hi3417 mutant embryos 5.78, 0.66                   Cyst sizes standardized dividing cyst area embryo length. drug-treated embryos (Table 2) (P , 0.0005).                          
                                                                                  P , 0.0005.
ift81 hi409, standardized cyst size 2.58 DMSO-                     
                                                                                   P , 0.04.
treated samples, 0.25 drug-treated embryos
(Table 2) (P , 0.04).  curvature                           cilia antibody ciliary protein, Scorpion/Arl13b
embryos affected rapamycin treatment (Fig. 5C).                    (47). examined cilia pronephric duct. wild- rule possibility curvature phenotype                      type embryos, average length cilia 7.4 mm (Fig. 6A caused defects earlier development, treated                       E), consistent previously published results (18).
embryos 200 nM rapamycin 10 hpf, time                            Intriguingly, cilia tsc1a morphants reach 12.4 mm point lengthening trunk.  curvature               average (Fig. 6B E). cilia pronephric duct tend
phenotype suppressed rapamycin treatment (data                     bundle complicate measure- shown), suggesting rapamycin partially                      ment cilia length, measured cilia length otic
rescue ift mutants.                                                           vesicles.  cilia length uninjected
                                                                              control embryos measured 1.8 mm (Fig. 6C E),                                                                               tsc1a embryos averaged 3.1 mm (Fig. 6D E),
Ciliary length increased tsc1a morphants                                suggesting disrupted cilia length control systemic tsc1a morphants identical phenotypes ift                    tsc1a morphant embryos. bar graph Figure 6E summar-
mutants functions ift genes thought                   izes results. previously demonstrated exclusively cilia-related, analyzed formation                   lack ciliary beating zebrafish pronephric duct cilium tsc1a morphants. fixed tsc1a morphants                        lead formation kidney cysts (18).  ana-
20 hpf labeled basal body anti-g tubulin                    lyzed motility cilia ducts tsc1a morphant
 602       Human Molecular Genetics, 2009, Vol. 18,  4




Figure 6. Cilia longer normal otic vesicles pronephric ducts tsc1a morphants. Cilia basal bodies embryos 1 dpf  B) 20-somite (C D) stages fluorescently labeled using antibodies Scorpion (Arl13b), ciliary protein g-tubulin. Confocal series captured using Zeiss LSM 510 Meta. LSM Image Browser software used measure ciliary length basal body distal tip  bar
graph (E) results]. Cilia pronephric ducts wild-type embryos average 7.4 mm, kidneys Tsc1a embryos average
12.4 mm long ( P , 0.0003). (B) Average cilia length otic vesicles wild-type embryos measured 1.8 mm;  otic vesicle cilia aver-
aged 3.1 mm ( P , 0.01) knock Tsc1a. (F) Cilia pronephric ducts tsc1a embryos beat rate similar WT ducts. Bar graph
illustrating average beats/second cilia pronephric ducts WT (42.5, n ¼ 5) tsc1a morphant (49, n ¼ 3) embryos. difference stat-
istically significant (P ¼ 0.4). WT, wild type; tsc1a, tsc1a morphant.


embryos using Metamorph. anterior ducts wild-type,                     functional connection cilium
day 3 embryos, measured average ciliary beating                            Tsc genes. Literature question limited intri-
42.5+11.1 beats/s (n ¼ 5), agreement pre-                       guing. Tsc1 Tsc2 heterozygous mice (Tsc1þ/2, vious reports (Supplementary Material, Movie S1) (18).                        Tsc2þ/2), prominent phenotype renal extra- observed anterior pronephric duct cilia                   renal tumors (28,29).  homozygous mutants similar staged tsc1a morphant embryos beat average                         Tsc1 Tsc2 die embryonic day 10.5 rate 49+11.8 beats/s (n ¼ 3) (Supplementary Material,                         open neural tube (28,29), phenotype seen multiple
Movie S2), significant difference (P ¼ 0.40, bar                     ciliary mutants mouse (8).
graph, Fig. 6F).  knock tsc1a does                            study, provided phenotypic, genetic bio-
severely affect frequency cilia beating.                                      chemical evidence support existence func-
                                                                                 tional link cilium TSC/TOR pathway.
                                                                                 observed knockdown tsc1a zebrafish leads DISCUSSION                                                                       body curvature, kidney cyst formation defects establish-
                                                                                 ing left – right asymmetry body plan, phenotypes charac- cilium affects Tor pathway upstream S6K                             teristic ciliary mutants. additionally observed critical role cilium kidney cyst formation,                        partial knockdown tsc1a ift genes synergized observation kidney cyst formation                         supporting common functions tsc1a ift
TSC patients rodent models, prompted ask                               genes. findings phosphorylated p70S6K elevated
                                                                          Human Molecular Genetics, 2009, Vol. 18,  4            603

 tsc1a ift morphants TOR inhibitor rapamy-        formation. Surprisingly, cilia elongated tsc1a mor-
cin inhibit cyst formation ift mutants suggest ciliary   phants. length cilia different tissues diverse signals feed TOR pathway upstream p70S6K.                stereotypic. example, cilia zebrafish pronephric
   results agreement previous studies,          duct range 7 9 mm long, cilia zebrafish
suggesting connection TOR pathway                  spinal canal 2 mm long (18). Genetic screens PKD. shown TOR pathway inappropriately            Chlamydomonas yielded long-flagella mutants (lf1-4)
activated cyst-lining epithelial cells rapamycin         (56 – 59). LF genes encode kinases (57,58),
treatment able reduce size polycystic               suggesting potential signaling cascade involved kidneys mouse models (30).                                        cilia length control. Long cilia    molecular nature connection mTOR           jck/Nek8 mouse develops PKD (60,61). Intriguingly,
pathway PKD controversial. example, shown          treatment Chlamydomonas GSK3 inhibitor tissue culture study TSC2 required proper       lithium induce flagellar elongation (59), pointing membrane localization PKD1 (31), suggesting PKD1             possible role Wnt pathway ciliary length control.
functions downstream TSC2. reported          result particularly interesting light recent findings
cytoplasmic tail PKD1 binds TSC2 mTOR              genes involved ciliary functions regulate Wnt path-
retarget TSC2 mTOR Gogli apparatus (30),                  ways (5,10,62,63). Alternatively, regulation cilia length putting PKD1 upstream TSC2 mTOR. Future chal-                 GSK3 occur independent Wnt pathway. lenges clarify molecular connection           example, previously demonstrated cilium TOR pathway, especially determine              absence TSC1 TSC2, p70S6K directly inhibit step TOR pathway ciliary               GSK3 phosphorylation (64). Exactly inhi-
signal incorporated.                                              bition lead long cilia unclear;                                                                       defect ciliary length represent global misregulation
                                                                     microtubule growth previously suggested
TSC genes trafficking                                            (59), TSC22/2 cells grow elongated microtubules study, Tsc1a associated Golgi       fail halt cell cortex. Interestingly, defect
complex blastula stage differentiated kidney      rescued reduction microtubule tip-binding
epithelial cells, raising interesting possibility       protein CLIP-170 rapamycin treatment (65).
aspect Tsc1a function controlling protein trafficking             result cilia abnormally long tsc1a morphants Golgi, turn mediates signal           implicates TOR pathway size control organelle. cilium.  best-known function TSC          possible feedback mechanism downstream complex restrain activity mTOR Rheb,          cilium plays role regulating cilia length. example, sig- appreciated area potential role Tsc1           naling activity cilium serve indicator Tsc2 protein trafficking. fission yeast, TSC1         cilia assembly/maintenance machinery functional cilium
TSC2 required proper targeting amino acid          formed downregulates machinery. permease plasma membrane (48). mammalian cells,            model, Tsc1a regulates cilia length indirectly functioning TSC complex reported involved post-Golgi            downstream cilium. Consistently, recent study Cae-
transport VSVG caveolin-1 (49). Tsc22/2 cells,             norhabditis elegans sensory neurons demonstrates caveolin-1 restricted cytoplasmic vesicles            structure cilium remodeled response abnormal
treatment rapamycin restore localization         levels sensory activity (66). Currently, multiple
plasma membrane (49). Interestingly, trafficking              players identified cilia length control, PKD1 cell membrane reported require functional         players function achieve control remains unclear.
TSC2 cultured cells (31). Various subcellular localization
patterns reported TSC1 TSC2 (49 – 54). patterns consistent trafficking role.         MATERIALS METHODS example, TSC2 shown component                Fish strains husbandry
lipid rafts (49). addition, proteins reported vesicular structures cytosol (50,51). Furthermore,      Zebrafish raised maintained standard protocols expression membrane-tethered N-terminal region          (67). Wild-type embryos derived crosses Tab 5
PKD1 shown retarget TSC2 cytosol              Tab 14 adult fish. Mutant embryos generated het-
Golgi (30). relationship TSC IFT                 erozygous crosses.
involve trafficking IFT20 known shuttle Golgi cilium believed help
deliver ciliary membrane proteins polycystin-2            Constructs, morpholinos mRNAs cilium (55).                                                     Morpholinos targeted translational start sites include                                                                      following: standard control morpholino: 50 -CCTCTTACCTC
                                                                     AGTTACAATTTATA-30 ; Tsc1a: 50 -CCATAGTTGTGCA
Tsc1 cilia length control
                                                                     GGACAGTGGGCA-30 ; 50 -AGAGATCAGTCCTCACCTTC study, knockdown tsc1a zebrafish          ACCAC-30 ; Tsc1a mismatch control: 50 -CCATACTTCTGC
leads phenotypes seen ift mutants. IFT genes            AGCACACTGGCCAA-30 ; Ift81: 50 -CGATAAATTTAAGC
essential cilia biogenesis, tsc1a involved cilia     TGTTCGCTCAT-30 Ift172: 50 -GACTCAGGGCAGTTA
 604     Human Molecular Genetics, 2009, Vol. 18,  4


TAAGAACGTA-30 . Base pairs 1879– 2373 (amplified                 Electron microscopy
using primers 50 -CAGAATTCCCGAAGGTGGCATCTCTG
                                                                 hpf embryos fixed Karnovsky fixative
TTTTT-30 50 -GCTCTAGATTAATGGTGATGGTGAT
                                                                 1 h 48C, washed 0.1 M sodium cacodylate, pH
GGTGCTCTCTGTCTTCCTGTATGTGC-30 ) 3079 – 3496                   7.4, post-fixed Palade’s osmium 1 h 48C,
(using primers 50 -CAGAATTCTCTCTACCGGCTGACCTG                    shielded light. Following second wash, embryos 30 50 -GCTCTAGATTAATGGTGATGGTGATGGTGG                      stained Kellenburger’s solution 1 h RT, washed
TCCTGATGCCTCCTACTCTG-30 ) Tsc1a-coding                  double distilled water, ethanol series,
region subcloned EcoRI XbaI sites pMAL      propylene oxide, 50/50 propylene oxide/epon, incu-
C2 (New England Biolabs, ) generate MBP fusion proteins   bations 100  epon. Embedded embryos sectioned 30 6x tags. produced proteins purified     400 nm staining 2  uranyl acetate. Micrographs
amylose columns used antigens generate polyclonal      taken Zeiss 910 electron microscope.
antisera TSC1-1 TSC1-2, respectively.

                                                                 mount immunostaining
Morpholino mRNA injections                                   Embryos various time points fixed formalin 0.125– 0.500 pmol translational start site blocking    Dent’s fixative (80  methanol 20  DMSO). Formalin-
morpholinos 50– 100 ng vitro synthesized mRNAs             fixed samples permeabilized ice cold acetone. injected embryos 1 –4-cell stage. Embryos       Embryos blocked 10  fetal bovine serum developed 28.58C embryo medium (5 mM NaCl,                 phosphate-buffered saline, 0.1  Tween-20 (PBT) incu-
0.2 mM KCl, 0.3 mM CaCl2, 0.7 mM MgSO4, 11025                   bation primary antibodies blocking solution. methylene blue).                                                 secondary antibody incubation, embryos washed
                                                                 extensively PBT. Embryos deyolked                                                                  mounted using Vectashield mounting medium (Vector Labora-
                                                                 tories) Prolong Gold (Invitrogen/Molecular Probes). Images
Preparation embryo lysates western blots                  captured using Zeiss 510 Meta confocal microscope Embryo lysates prepared 24 – 48 hpf embryos        Zeiss Axioplan microscope processed using Photoshop.
previously described (68) minor modifications. Prepared
samples loaded 4 – 20  Tris – HCl mini gradient        High-speed videomicroscopy
gels (BioRad), transferred nitrocellulose. Immunoblots carried using Tris-buffered saline (TBS), pH 7.4, 5     previously published protocol followed (18) milk, 0.1  Tween 20 primary secondary antibodies.        minor modifications. Embryos incubated 75 mM phe- final wash TBS, 0.5  Triton X-100, blots         nylthiourea embryo medium starting day 1. day 3,
incubated Western Lightning Chemiluminescence Plus            embryos mounted 6  methylcellulose containing
(PerkinElmer LAS, ) exposed film.                     50 mM 2,3-butanedione monoxime 0.02  tricaine. Cilia
                                                                 beating recorded using 20/0.4 DIC lens Nikon
                                                                 Eclipse TE2000-U microscope equipped Nikon
                                                                 Photometrics Coolsnap HQ camera stream acquisition
Antibodies
                                                                 200 frames/s 1 s, analyzed converted avi
Antibodies used include TSC1-1 TSC1-2 polyclonal             format using Metamorph v8.1.2.0. Movies played 10
antibodies (Sigma-Genosys); anti-Scorpion polyclonal anti-       frames/s.
body (Covance); BD Biosciences: gm130, anti-IRS-1 anti-p70 S6K; Cell Signaling: anti-Phospho-p70 S6 Kinase
(Thr389) Sigma: anti-b tubulin Clone 2.1, anti-acetylated    SUPPLEMENTARY MATERIAL tubulin. Secondary antibodies Jackson Immuno          Supplementary Material available HMG online.
Research Labs Invitrogen/Molecular Probes.

                                                                 ACKNOWLEDGEMENTS
Quantification Western blots                                  thank Arthur Horwich critical review manu-
X-ray films scanned 300 dpi analyzed using      script, SueAnn Mentone superb skills histology
AutoQuant software, version X1.4.1 (Media Cybernetics).          EM, members Yale Center PKD Research Values sample normalized background        comments suggestions, Reinke Somlo
subtraction divided value correspond-    labs technical support use equipment.
ing b-tubulin band.
                                                                 Conflict statement. declared.


Statistical analysis                                             FUNDING
P-values derived Student’s t-test using            work supported grants United States
Microsoft Excel.                                                 Army Medical Research Material Command
                                                                                           Human Molecular Genetics, 2009, Vol. 18,  4                       605


(W81XWH-07-10235 S.), National Institute Dia-                            20. Fliegauf, M., Benzing, T. Omran, H. (2007) cilia bad: cilia
betes Digestive Kidney Diseases (ROI DK069528                                    defects ciliopathies. Nat. Rev. Mol. Cell Biol., 8, 880–893.
                                                                                     21. Pazour, G.J. Witman, G.B. (2003) vertebrate primary cilium S.) Tuberous Sclerosis Alliance L.M.D.                              sensory organelle. Curr. Opin. Cell Biol., 15, 105– 110.
                                                                                     22. Astrinidis,  Henske, E.P. (2005) Tuberous sclerosis complex:
                                                                                         linking growth energy signaling pathways human disease.
                                                                                         Oncogene, 24, 7475– 7481.
REFERENCES                                                                           23. Green, J., Smith, M. Yates, J.R. (1994) Loss heterozygosity  1. Schneider, L., Clement, C , Teilmann, S.C., Pazour, G.J., Hoffmann,                chromosome 16p13.3 hamartomas tuberous sclerosis patients.
    E.K., Satir, P. Christensen, S.T. (2005) PDGFRalphaalpha signaling            Nat. Genet., 6, 193– 196.
    regulated primary cilium fibroblasts. Curr. Biol., 15, 1861–      24. Yeung, R.S., Buetow, K.H., Testa, J.R. Knudson, G. Jr. (1993)
    1866.                                                                                Susceptibility renal carcinoma Eker rat involves tumor
 2. Handel, M., Schulz, S., Stanarius, , Schreff, M., Erdtmann-Vourliotis,             suppressor gene chromosome 10. Proc. Natl Acad. Sci. USA, 90,
    M., Schmidt, H., Wolf, G. Hollt, V. (1999) Selective targeting                8038–8042.
    somatostatin receptor 3 neuronal cilia. Neuroscience, 89, 909– 926.           25. Cai, S., Everitt, J , Kugo, H., Cook, J., Kleymenova, E. Walker, C.L.
 3. Berbari, N.F., Lewis, J.S., Bishop, G , Askwith, C.C. Mykytyn, K.              (2003) Polycystic kidney disease result loss tuberous
    (2008) Bardet–Biedl syndrome proteins required localization              sclerosis 2 tumor suppressor gene development.  J. Pathol.,
    G protein-coupled receptors primary cilia. Proc. Natl Acad. Sci.               162, 457–468.
    USA, 105, 4242– 4246.                                                            26. Ong, C., Harris, P.C., Davies, D.R., Pritchard, L., Rossetti, S.,
 4. Corbit, K.C., Aanstad, P., Singla, V., Norman, R., Stainier, D.Y.              Biddolph, S., Vaux, D.J., Migone, N. Ward, C.J. (1999) Polycystin-1
    Reiter, J.F. (2005) Vertebrate smoothened functions primary cilium.           expression PKD1, early-onset PKD1, TSC2/PKD1 cystic tissue.
    Nature, 437, 1018–1021.                                                              Kidney Int., 56, 1324–1333.
 5. Corbit, K.C., Shyer, E., Dowdle, W.E., Gaulden, J., Singla, V., Chen,          27. Huang, J. Manning, B.D. (2008) TSC1–TSC2 complex:     M.H., Chuang, P.T. Reiter, J.F. (2008) Kif3a constrains                          molecular switchboard controlling cell growth. Biochem. J., 412, 179–
    beta-catenin-dependent Wnt signalling dual ciliary                       190.
    non-ciliary mechanisms. Nat. Cell Biol., 10, 70–76.                              28. Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O. Noda, T.
 6. Gerdes, J.M., Liu, Y., Zaghloul, N , Leitch, C.C., Lawson, S.S., Kato,             (1999) Renal carcinogenesis, hepatic hemangiomatosis, embryonic
    M., Beachy, P , Beales, P.L., DeMartino, G.N., Fisher, S. et al. (2007)            lethality caused germ-line Tsc2 mutation mice. Cancer Res., 59,
    Disruption basal body compromises proteasomal function                    1206–1211.
    perturbs intracellular Wnt response. Nat. Genet., 39, 1350–1360.                 29. Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H.,
 7. Huangfu, D. Anderson, K.V. (2005) Cilia Hedgehog                             Kobayashi, E., Noda, T. Hino, O. (2001) germ-line Tsc1 mutation
    responsiveness mouse. Proc. Natl Acad. Sci. USA, 102, 11325–                  causes tumor development embryonic lethality similar,     11330.                                                                               identical  caused Tsc2 mutation mice. Proc. Natl Acad.
 8. Huangfu, D., Liu, , Rakeman, S., Murcia, N.S., Niswander, L.                 Sci. USA, 98, 8762–8767.
    Anderson, K.V. (2003) Hedgehog signalling mouse requires                  30. Shillingford, J.M., Murcia, N.S., Larson, C.H., Low, S.H., Hedgepeth, R.,
    intraflagellar transport proteins. Nature, 426, 83– 87.                              Brown, N., Flask, C , Novick, C., Goldfarb, D , Kramer-Zucker, 
 9. Kim, E., Arnould, T., Sellin, L.K., Benzing, T., Fan, M.J., Gruning, W.,             et al. (2006) mTOR pathway regulated polycystin-1,     Sokol, S.Y., Drummond,  Walz, G. (1999) polycystic kidney                  inhibition reverses renal cystogenesis polycystic kidney disease. Proc.
    disease 1 gene product modulates Wnt signaling. J. Biol. Chem., 274,                 Natl Acad. Sci. USA, 103, 5466–5471.
    4947– 4953.                                                                      31. Kleymenova, E., Ibraghimov-Beskrovnaya, O., Kugoh, H., Everitt, J., Xu,
10. Oishi, , Kawakami, Y., Raya, , Callol-Massot, C. Izpisua                     H., Kiguchi, K., Landes, G., Harris, P. Walker, C. (2001)
    Belmonte, J.C. (2006) Regulation primary cilia formation left-right           Tuberin-dependent membrane localization polycystin-1: functional
    patterning zebrafish noncanonical Wnt signaling mediator,                    link polycystic kidney disease TSC2 tumor suppressor
    duboraya. Nat. Genet., 38, 1316–1322.                                                gene. Mol. Cell, 7, 823– 832.
11. Park, T.J., Haigo, S.L. Wallingford, J.B. (2006) Ciliogenesis defects        32. Drummond, , Majumdar, , Hentschel, H., Elger, M., Solnica-Krezel,
    embryos lacking inturned fuzzy function associated failure            L., Schier, F., Neuhauss, S.C., Stemple, D.L., Zwartkruis, F., Rangini,
    planar cell polarity Hedgehog signaling. Nat. Genet., 38, 303–311.             et al. (1998) Early development zebrafish pronephros 12. Rosenbaum, J.L. Witman, G.B. (2002) Intraflagellar transport. Nat.               analysis mutations affecting pronephric function. Development, 125,
    Rev. Mol. Cell Biol., 3, 813– 825.                                                   4655–4667.
13. Kozminski, K.G., Johnson, K , Forscher, P. Rosenbaum, J.L. (1993)          33. Makky, K., Tekiela, J. Mayer, N. (2007) Target rapamycin
    motility eukaryotic flagellum unrelated flagellar beating. Proc.         (TOR) signaling controls epithelial morphogenesis vertebrate
    Natl Acad. Sci. USA, 90, 5519–5523.                                                  intestine. Dev. Biol., 303, 501 –513.
14. Pazour, G.J., Dickert, B.L., Vucica, Y., Seeley, E.S., Rosenbaum, J.L.,          34. Supp, D.M., Witte, D.P., Potter, S.S. Brueckner, M. (1997) Mutation
    Witman, G.B. Cole, D.G. (2000) Chlamydomonas IFT88                       axonemal dynein affects left –right asymmetry inversus viscerum
    mouse homologue, polycystic kidney disease gene tg737, required              mice. Nature, 389, 963–966.
    assembly cilia flagella. J. Cell Biol., 151, 709–718.                     35. Brody, S.L., Yan, X.H., Wuerffel, M.K., Song, S.K. Shapiro, S.D.
15. Yoder, B.K., Tousson, , Millican, L., Wu, J.H., Bugg, C.E. Jr, Schafer,            (2000) Ciliogenesis left–right axis defects forkhead factor
    J  Balkovetz, D.F. (2002) Polaris, protein disrupted orpk mutant          HFH-4-null mice.  J. Respir. Cell Mol. Biol., 23, 45–51.
    mice, required assembly renal cilium.  J. Physiol. Renal.           36. Chen, J.N., van Eeden, F.J., Warren, K.S., Chin, , Nusslein-Volhard, C.,
    Physiol., 282, F541– F552.                                                           Haffter, P. Fishman, M.C. (1997) Left– right pattern cardiac BMP4
16. Taulman, P.D., Haycraft, C.J., Balkovetz, D.F. Yoder, B.K. (2001)                drive asymmetry heart zebrafish. Development, 124, 4373–
    Polaris, protein involved left– right axis patterning, localizes basal       4382.
    bodies cilia. Mol. Biol. Cell, 12, 589 –599.                                 37. Marszalek, J.R., Ruiz-Lozano, P., Roberts, E., Chien, K.R. Goldstein,
17. Sun, , Amsterdam, , Pazour, G.J., Cole, D.G., Miller, M.S.                   L.S. (1999) Situs inversus embryonic ciliary morphogenesis defects     Hopkins, N. (2004) genetic screen zebrafish identifies cilia genes         mouse mutants lacking KIF3A subunit kinesin-II. Proc. Natl Acad.
    principal cause cystic kidney. Development, 131, 4085– 4093.                      Sci. USA, 96, 5043–5048.
18. Kramer-Zucker, G., Olale, F., Haycraft, C.J., Yoder, B.K., Schier, F.        38. Nonaka, S., Tanaka, Y., Okada, Y., Takeda, S., Harada, , Kanai, Y.,
    Drummond,  (2005) Cilia-driven fluid flow zebrafish                   Kido, M. Hirokawa, N. (1998) Randomization left–right
    pronephros, brain Kupffer’s vesicle required normal                       asymmetry loss nodal cilia generating leftward flow     organogenesis. Development, 132, 1907–1921.                                          extraembryonic fluid mice lacking KIF3B motor protein. Cell, 95, 829–
19. Gabow, P  Grantham, J. (1997) Polycystic kidney disease.                    837.
    Gottschalk, R.S C. (ed.), Diseases Kidney, Little Brown, Boston,        39. Zhao, C. Malicki, J. (2007) Genetic defects pronephric cilia     MA, pp. 521– 560.                                                                    zebrafish. Mech. Dev., 124, 605 –616.
 606       Human Molecular Genetics, 2009, Vol. 18,  4


40. Astrinidis, , Senapedis, W. Henske, E.P. (2006) Hamartin,                 muscle cells driven multiple localization sequences cell-cycle
    tuberous sclerosis complex